BioCentury
ARTICLE | Company News

BioInvent cardiovascular news

June 7, 2010 7:00 AM UTC

BioInvent said investor Stiftelsen Industrifonden sold its entire 7.3% stake in the company, or about 4.5 million shares, to Swedish and European institutional investors. At Dec. 31, 2009, Stiftelsen Industrifonden was the second largest shareholder in BioInvent. Oehman Fondkommission and Kempen & Co. were financial advisors and placement agents in the deal. ...